In a screening study for gastric cancer surface markers, Takaishi et al(17) demonstrated that CD44+ gastric cancer cells have stronger in vivo proliferation and tumor formation ability compared with CD44− cells, suggesting that the former have biological characteristics similar to those of tumor stem cells. The gene discussed is CD44; the disease is gastric cancer.